Is INXB or FCPT a better dividend investment in 2026?

INXB currently yields 12.61% with a 5% 5-year dividend growth rate. FCPT yields 6.05% with 5% growth. The better choice depends on your goal: INXB offers higher current income.

What is the dividend yield difference between INXB and FCPT?

INXB has a forward dividend yield of 12.61% ($2.00/share annually). FCPT yields 6.05% ($1.43/share annually). The yield gap is 6.56 percentage points.

Home › Compare › INXB vs FCPT

INXB vs FCPT: Dividend Comparison 2026

INXB yields 12.61% · FCPT yields 6.05%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 FCPT wins by $3.2K in total portfolio value· pulled ahead in Year 9

INVESTMENT

TIME HORIZON10 years

INXB

● Live price

12.61%

Share price

$15.86

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$45.9K

Annual income

$2,765.46

Full INXB calculator →

FCPT

● Live price

6.05%

Share price

$23.65

Annual div

$1.43

5Y div CAGR

15.8%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$49.1K

Annual income

$5,775.28

Full FCPT calculator →

Portfolio growth — INXB vs FCPT

📍 FCPT pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	INXB	FCPT
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, INXB + FCPT cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

INXB pays

FCPT pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

INXB

Annual income on $10K today (after 15% tax)

$1,071.88/yr

After 10yr DRIP, annual income (after tax)

$2,350.64/yr

FCPT

Annual income on $10K today (after 15% tax)

$514.49/yr

After 10yr DRIP, annual income (after tax)

$4,908.99/yr

At 15% tax rate, FCPT beats the other by $2,558.35/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of INXB + FCPT for your $10,000?

INXB: 50%FCPT: 50%

100% FCPT50/50100% INXB

Portfolio after 10yr

$47.5K

Annual income

$4,270.37/yr

Blended yield

8.99%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

INXB

No analyst data

FCPT

Analyst Ratings

Buy

Hold

Consensus: Hold

Price Target

$27.00

+14.2% upside vs current

Range: $25.00 — $29.00

Altman Z

1.4

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

INXB buys

FCPT buys

No recent congressional trades found for INXB or FCPT in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricINXBFCPT

Forward yield	12.61% ✓	6.05%
Annual dividend / share	$2.00 ✓	$1.43
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.8% ✓
Portfolio after 10y	$45.9K	$49.1K ✓
Annual income after 10y	$2,765.46	$5,775.28 ✓
Total dividends collected	$19.9K	$24.1K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	REIT

Year-by-year: INXB vs FCPT ($10,000, DRIP)

Year	INXB Portfolio	INXB Income/yr	FCPT Portfolio	FCPT Income/yr	Gap
1	$11,961	$1,261.03	$11,401	$700.92	+$560.00 → INXB
2	$14,208	$1,409.65	$13,064	$864.84	+$1.1K → INXB
3	$16,767	$1,564.92	$15,051	$1,072.48	+$1.7K → INXB
4	$19,667	$1,726.00	$17,442	$1,337.22	+$2.2K → INXB
5	$22,936	$1,892.05	$20,340	$1,677.08	+$2.6K → INXB
6	$26,604	$2,062.17	$23,880	$2,116.57	+$2.7K → INXB
7	$30,701	$2,235.45	$28,241	$2,689.36	+$2.5K → INXB
8	$35,261	$2,411.00	$33,660	$3,442.07	+$1.6K → INXB
9← crossover	$40,318	$2,587.95	$40,456	$4,439.95	$138.00 → FCPT
10	$45,905	$2,765.46	$49,063	$5,775.28	$3.2K → FCPT

INXB vs FCPT: Complete Analysis 2026

INXB — Stock

Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates includes INBRX-109, a tetravalent therapeutic candidate targeting death-receptor 5 that is in phase 2 clinical trial for the treatment of unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 that is in phase 2 clinical trial for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head and neck cancer, gastric (GIST) and gastroesophageal adenocarcinoma (GEA) cancer, renal cell carcinoma, and urothelial (transitional) cell carcinoma. The company was incorporated in 2024 and is based in La Jolla, California.

Full INXB Calculator →

FCPT — REIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →

📬

Get this INXB vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

INXB vs SCHD INXB vs JEPI INXB vs O INXB vs KO INXB vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.